Literature DB >> 24322653

Reproductive endocrinology: New guidelines for the diagnosis and treatment of PCOS.

Francesco Orio1, Stefano Palomba2.   

Abstract

An Endocrine Society-appointed task force has developed an evidence-based clinical practice guideline for the diagnosis and treatment of polycystic ovary syndrome. The guidelines provide suggestions for the management of patients with polycystic ovary syndrome and highlight many areas of uncertainty requiring further scientific efforts.

Entities:  

Mesh：

Year:  2013        PMID： 24322653     DOI： 10.1038/nrendo.2013.248

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  10 in total

1.  Cardiovascular risk in women with polycystic ovary syndrome.

Authors:  Francesco Orio; Stefano Palomba; Annamaria Colao
Journal:  Fertil Steril       Date:  2006-07       Impact factor: 7.329

2.  Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Johanna Puurunen; Terhi Piltonen; Katri Puukka; Aimo Ruokonen; Markku J Savolainen; Risto Bloigu; Laure Morin-Papunen; Juha S Tapanainen
Journal:  J Clin Endocrinol Metab       Date:  2013-10-23       Impact factor: 5.958

Review 3.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

Review 4.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

5.  Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes.

Authors:  Stefano Palomba; Angela Falbo; Tiziana Russo; Achille Tolino; Francesco Orio; Fulvio Zullo
Journal:  Fertil Steril       Date:  2009-12-11       Impact factor: 7.329

Review 6.  Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.

Authors:  Stefano Palomba; Angela Falbo; Fulvio Zullo; Francesco Orio
Journal:  Endocr Rev       Date:  2008-12-04       Impact factor: 19.871

7.  Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.

Authors:  Paolo Moghetti; Flavia Tosi; Cecilia Bonin; Daniela Di Sarra; Tom Fiers; Jean-Marc Kaufman; Vito Angelo Giagulli; Chiara Signori; Francesca Zambotti; Marlene Dall'Alda; Giovanna Spiazzi; Maria Elisabetta Zanolin; Enzo Bonora
Journal:  J Clin Endocrinol Metab       Date:  2013-03-08       Impact factor: 5.958

8.  Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.

Authors:  Suleena Kansal Kalra; Sarah J Ratcliffe; Anuja Dokras
Journal:  Fertil Steril       Date:  2013-04-01       Impact factor: 7.329

Review 9.  Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Marie L Misso; Michael F Costello; Marie Garrubba; Jennifer Wong; Roger Hart; Luk Rombauts; Angela M Melder; Robert J Norman; Helena J Teede
Journal:  Hum Reprod Update       Date:  2012-09-06       Impact factor: 15.610

10.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958
  10 in total
  19 in total

1.  Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept.

Authors:  F Orio; G Muscogiuri; S Palomba
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

2.  Worldwide Dissatisfaction With the Diagnostic Process and Initial Treatment of PCOS.

Authors:  Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

3.  RS1799817 in INSR associates with susceptibility to polycystic ovary syndrome.

Authors:  Maha H Daghestani
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

4.  Tai Chi for Overweight/Obese Adolescents and Young Women with Polycystic Ovary Syndrome: A Randomized Controlled Pilot Trial.

Authors:  Yan Li; Changle Peng; Meiwei Zhang; Liangzhen Xie; Jinjin Gao; Yingji Wang; Yuanhe Gao; Lihui Hou
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-17       Impact factor: 2.650

5.  Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.

Authors:  Vitaly A Kushnir; Noy Halevy; David H Barad; David F Albertini; Norbert Gleicher
Journal:  J Ovarian Res       Date:  2015-07-09       Impact factor: 4.234

6.  Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population.

Authors:  Ming-Wei Lin; Mei-Feng Huang; Meng-Hsing Wu
Journal:  J Ovarian Res       Date:  2014-10-14       Impact factor: 4.234

Review 7.  Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.

Authors:  Maria A Sortino; Salvatore Salomone; Michele O Carruba; Filippo Drago
Journal:  Front Pharmacol       Date:  2017-06-08       Impact factor: 5.810

8.  Tai chi for overweight/obese adolescent and young women with polycystic ovary syndrome: study protocol for a randomized controlled trial.

Authors:  Yan Li; Changle Peng; Guangying Cao; Wei Li; Lihui Hou
Journal:  Trials       Date:  2018-09-20       Impact factor: 2.279

Review 9.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31

Review 10.  Inositols in the Treatment of Insulin-Mediated Diseases.

Authors:  Giovanna Muscogiuri; Stefano Palomba; Antonio Simone Laganà; Francesco Orio
Journal:  Int J Endocrinol       Date:  2016-09-08       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.